# US 6,727,250 B2 · Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and preparation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,250 B2
- Document ID: US6727250B2
- Status: Granted
- Kind: B2
- Application number: 10/037,555
- Filed: 2002-01-03
- Published: 2002-07-25
- Granted: 2004-04-27
- Earliest claimed: 1999-07-27
- Assignees: Boehringer Ingelheim Pharma GmbH & Co. KG
- Inventors: Norbert Hauel; Henning Priepke; Klaus Damm; Andreas Schnapp
- Web page: https://patentgrep.com/patent/US6727250B2

## CPC

- C07D 295/192: from aromatic carboxylic acids
- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61P 17/06: Antipsoriatics
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 33/00: Antiparasitic agents
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 233/55: having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
- C07C 233/63: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C 233/81: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C 235/38: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C 237/30: having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
- C07C 237/42: having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
- C07C 237/52: having the nitrogen atom of at least one of the carboxamide groups further acylated
- C07C 243/38: with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
- C07C 255/24: containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C 271/20: to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
- C07C 271/28: to a carbon atom of a non-condensed six-membered aromatic ring
- C07C 275/42: being further substituted by carboxyl groups
- C07C 309/51: at least one of the nitrogen atoms being part of any of the groups [IMAGE cpc-sch-C07C-0976.gif], X being a hetero atom, Y being any atom
- C07C 309/66: Methanesulfonates
- C07C 311/08: having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C 311/21: having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C 311/39: having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C 311/51: Y being a hydrogen or a carbon atom
- C07D 213/53: Nitrogen atoms
- C07D 213/56: Amides
- C07D 213/75: Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C07D 213/79: Acids; Esters
- C07D 215/56: with oxygen atoms in position 4
- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 231/14: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 233/26: Radicals substituted by carbon atoms having three bonds to hetero atoms
- C07D 233/88: Nitrogen atoms, e.g. allantoin
- C07D 233/90: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 235/08: Radicals containing only hydrogen and carbon atoms
- C07D 257/04: Five-membered rings
- C07D 295/155: with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07D 307/79: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D 311/06: with oxygen or sulfur atoms directly attached in position 2
- C07D 311/12: substituted in position 3 and unsubstituted in position 7
- C07D 317/50: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D 333/36: Nitrogen atoms
- C07D 333/38: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 333/60: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 405/04: directly linked by a ring-member-to-ring-member bond
- C07C 2601/02: with a three-membered ring
- C07C 2601/14: The ring being saturated
- C07C 2602/08: the other ring being five-membered, e.g. indane
- C07C 2602/10: the other ring being six-membered, e.g. tetraline
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Carboxylic acid amides of general formula which inhibit telomerase and are useful for treating tumor diseases such as carcinomas, sarcomas and leukaemias. Exemplary compounds are: (1) trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide, and, (2) trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-4,5-dimethoxy-phenyl)-amide.

## Claims

### Claim 1

A compound of the formula
wherein:
R1 denotes a C1-3-alkyl group,
R2 denotes a hydrogen, fluorine, chlorine or bromine atom, a C1-3-alkyl, C3-7-cycloalkyl or C1-3-alkoxy group,
R3 denotes a hydrogen atom or a C1-5-alkyl group,
R4 and R5 together denote another carbon-carbon bond,
A denotes a phenyl, group substituted by a fluorine, chlorine, bromine or iodine atom, whilst the abovementioned monosubstituted phenyl groups is additionally substituted by a fluorine, chlorine or bromine atom, and the abovementioned disubstituted phenyl groups may additionally be substituted by a C1-3-alkyl or C1-3-alkoxy group,
B denotes a phenyl group, which is substituted by a carboxy group, whilst the abovementioned phenyl groups may additionally be substituted
by a fluorine, chlorine, bromine or iodine atom,
by a C1-3-alkyl, trifluoromethyl, hydroxy, C1-3-alkoxy, C1-3-alkylsulphonyloxy, phenylsulphonyloxy, carboxy, C1-3-alkoxycarbonyl, formyl, C1-3-alkylcarbonyl, C1-3-alkylsulphonyl, phenylsulphonyl, nitro, pyrrolidino, piperidino, morpholino, N-(C1-3-alkyl)-piperazino, aminoulphonyl, C1-3-alkylaminosulphonyl or di-(C1-3alkyl)-aminosulphonyl group,
by a C1-3-alkyl group which is substituted by a hydroxy, C1-3-alkoxy, amino, C1-4-alkylamino, di-(C1-4-alkyl)-amino, C3-7-cycloalkylamino, pyrrolidino, piperidino, morpholino, piperazino or N-(C1-3-alkyl)-piperazino group,
by an n-C2-3-alkoxy, C2-3-alkenyl or C2-3-alkynyl group substituted in the 2 or 3 position by a di-(C1-3-alkyl)-amino group,
by an amino group, by an N-(C1-3-alkyl)-amino or N,N-di-(C1-3-alkyl)-amino group wherein the alkyl moiety may in each case be substituted in the 2 or 3 position in relation to the nitrogen atom by a C1-3-alkoxy group, by an N-phenylamino, N-(phenyl-C1-3-alkyl)-amino or N-(pyridyl-C1-3-alkyl)-amino group wherein in each case a hydrogen atom of the abovementioned amino groups may be substituted by a C1-3-al-kylsulphonyl, phenyl-C1-3-alkylsulphonyl or phenylsulphonyl group or by a C1-7-alkyl group which may be replaced in the 2 to 5 position by a C1-3-alkoxy, cyano, amino, C1-3-alkylamino, di-(C1-3-alkyl)-amino or tetrazolyl group,
by an aminocarbonyl or C1-3-alkylaminocarbonyl group which may in each case be substituted at the amino-nitrogen atom
by a C1-4-alkyl group which may be substituted by a vinyl, ethynyl, phenyl, pyridyl, imidazolyl, carboxy or trifluoromethyl group or, with the exception of the 2 position relative to the aminocarbonyl nitrogen atom, by a hydroxy, C1-3-alkoxy, C1-3-alkylthio, amino, C1-3-alkylamino, di-(C1-3-alkyl)-amino, C1-4-alkanoylamino or C1-5-alkoxycarbonylamino group,
by a C3-7-cycloalkyl, C5-9-azabicycloalkyl, phenyl, pyridyl, C1-3-alkoxy or di-(C1-3-alkyl)-amino group,
by a C1-3-alkyl group which is substituted by a piperidin-3-yl or piperidin-4-yl group optionally substituted in the 1 position by a C1-3-alkyl or C1-5-alkoxycarbonyl group, or
by an amino, C1-3-alkylamino or phenyl-C1-3-alkylamino group optionally substituted at the amino-nitrogen atom by a C1-4-alkanoyl, C1-5-alkoxycarbonyl, benzoyl, pyrrolidino, piperidino, morpholino or N-(C1-3-alkyl)-piperazino group,
by a carbonyl group substituted by a pyrrolidino, pyrrolino, piperidino, morpholino or N-(C1-3-alkyl)-piperazino group,
by a sulphonyl group substituted by an amino, C1-3-alkylamino, di-(C1-3-alkyl)-amino, pyrrolidino, piperidino, morpholino or N-(C1-3-alkyl)-piperazino group,
by an amino or N-(C1-3-alkyl)-amino group which may in each case be substituted at the amino-nitrogen atom by an aminocaxbonyl, C1-3-alkylaminocarbonyl, phenyl- C1-3-alkylaminocarbonyl, phenylaminocarbonyl, phenoxyphenylaminocarbonyl, pyridylaminocarbonyl, pyrrolidinocarbonyl, piperidinocarbonyl, morpholinocarbonyl or N-(C1-3-alkyl)-piperazinocarbonyl group, wherein additionally any hydrogen atom of one of the abovementioned aminocarbonyl groups present may be substituted by a C1-3-alkyl group,
by a dihydro-oxazolyl, dihydro-imidazolyl, 2-oxo-pyrrolidino, 2-oxo-piperidino or 2-oxo-hexamethyleneimino group to which a phenyl ring may be fused via two adjacent carbon atoms,
by an ethynyl group substituted by a phenyl, hydroxymethyl or dimethylamino group, whilst
additionally the abovementioned mono- or disubstituted phenyl groups may be substituted by another fluorine, chlorine or bromine atom or by one or two other C1-3-alkyl or C1-3-alkoxy groups and two C1-3-alkoxy groups in the o position may be replaced by a methylenedioxy group,
and the amino and imino groups mentioned in the definition of the abovementioned groups may additionally be substituted by a group which may be cleaved in vivo,
or a physiologically acceptable salt thereof.

### Claim 2 (depends on 1)

A compound of the formula I, according to claim 1, wherein:
B and R2 to R5 are defined as in claim 1,
R1 denotes a C1-3-alkyl group and
A denotes a phenyl, group substituted by a fluorine, chlorine, bromine or iodine, whilst the abovementioned monosubstituted phenyl group is additionally substituted by a fluorine, chlorine or bromine atom or a physiologically acceptable salt thereof.

### Claim 3 (depends on 1)

A compound of the formula I according to claim 1, wherein:
R1 denotes a C1-3-alkyl group,
R2 denotes a hydrogen atom
R3 denotes a hydrogen atom or a C1-5-alkyl group,
R4 and R5 together denote another carbon-carbon bond,
A denotes
a phenyl group substituted by fluorine, chlorine or bromine atoms, whilst the substituents may be identical or different, or
a C1-3-alkylphenyl group, which is disubstituted by fluorine, chlorine or bromine atoms, whilst the substituents may be identical or different,
B denotes
a phenyl group substituted by a carboxy, methoxycarbonyl, ethoxycarbonyl, hydroxymethyl, sulpho, tetrazolyl, methylsulphonylaminocarbonyl or phenylsulphonylaminocarbonyl group, which may additionally be substituted
by a fluorine, chlorine, bromine or iodine atom,
by a methyl, trifluoromethyl, hydroxymethyl, hydroxy, methoxy, methylsulphonyloxy, 2-dimethylamino-ethoxy, carboxy, nitro, methylsulphonylamino, phenylsulphonylamino, aminosulphonyl, pyrrolidino, piperidino or morpholino group,
by a methyl group which is substituted by an amino, C1-3-alkylamino, cyclopentylamino, pyrrolidino or piperidino group,
by an amino, N-methyl-amino or N-(2-methoxy-ethyl)-amino group which may in each case be substituted at the amino-nitrogen atom
by a C1-7-alkyl or phenyl group,
by an ethyl group which is substituted in the 1 or 2 position by a phenyl or pyridyl group,
by a C2-4-alkyl group which is terminally substituted by a methoxy, cyano, dimethylamino or tetrazolyl group,
by an acetyl, benzoyl, C1-5-alkoxycarbonyl, aminocarbonyl or methylaminocarbonyl group, whilst the aminocarbonyl moiety of the abovementioned groups may in each case additionally be substituted by an optionally phenyl-substituted C1-3-alkyl group,
by a phenyl, phenoxyphenyl or pyridyl group,
by a methylsulphonyl, phenylsulphonyl or benzylsulphonyl group,
by an aminocarbonyl or methylaminocarbonyl group which may in each case be substituted at the amino-nitrogen atom
by a C1-4-alkyl, C3-6-cycloalkyl, phenyl, benzyl, pyridyl, pyridylmethyl or methoxy group,
by a methyl group which is substituted by a vinyl, ethynyl, trifluoromethyl, C7-9-azabicycloalkyl, carboxy or imidazolyl group or by a piperidin-4-yl group optionally substituted in the 1 position by a methyl or C1-5-alkoxycarbonyl group,
by a straight-chain or branched C2-3-alkyl group substituted in the 2 or 3 position by a hydroxy, methoxy, methylthio, amino, acetylamino, C1-5-alkoxycarbonylamino, carboxy-, C1-5-alkoxycarbonyl or dimethylamino group,
by a pyrrolidino, piperidino, morpholino, 4-methyl-piperazino, amino or methylamino group, whilst the abovementioned amino and methylamino groups may each additionally be substituted at the amino-nitrogen atom by a methyl, acetyl, benzoyl or C1-5-alkoxycarbonyl group,
by a dihydro-oxazolyl, dihydro-imidazolyl, 2-oxo-pyrrolidino, 2-oxo-piperidino or 2-oxo-hexamethyleneimino group to which a phenyl ring may be fused via two adjacent carbon atoms,
by an ethynyl group substituted by a phenyl, hydroxymethyl or dimethylamino group, whilst
additionally the abovementioned mono- or disubstituted phenyl groups may be substituted by another fluorine, chlorine or bromine atom or by one or two other methyl or methoxy groups, or a physiologically acceptable salt thereof.

### Claim 4 (depends on 1)

A compound of the formula I according to claim 1, wherein:
R1 denotes a C1-3-alkyl group,
R2 denote a hydrogen,
R3 denotes a hydrogen atom,
R4 and R5 together denote another carbon-carbon bond,
A denotes a phenyl group mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, whilst the substituents may be identical or different,
B denotes a phenyl which is substituted by a carboxy group, whilst the abovementioned phenyl groups may additionally be substituted
by a fluorine, chlorine or bromine atom,
by a C1-3-alkyl, hydroxy, C1-3-alkoxy, C1-3-alkylsulphonyloxy, pyrrolidino, piperidino, morpholino or N-(C1-3-alkyl)-piperazino group,
by an n-C2-3-alkoxy, C2-3-alkenyl or C2-3-alkynyl group substituted in the 2 or 3 position by a di-(C1-3-alkyl)-amino group,
by an N-methyl-N-(n-C2-3-alloyl)-amino group substituted in the 2 or 3 position by a di- (C1-3-alkyl)-amino group,
by a di-(C1-3-alkyl)-amino group,
by a C1-4-alkylamilocarbonyl, N-(pyridinylmethyl)-aminocarbonyl, pyrrolidinoamino- carbonyl or piperidinoaminocarbonyl group and may additionally be substituted by another fluorine atom, by another C1-3-alkyl or C1-3-alkoxy group,
or a physiologically acceptable salt thereof.

### Claim 5

A compound of the formula I
R1 denotes a methyl group,
R2 denotes a hydrogen atom,
R3 denotes a hydrogen atom,
R4 and R5 together denote another carbon-carbon bond,
A denotes a phenyl group substituted by two chlorine or bromine atoms or by a chlorine atom and a bromine atom,
and B denotes a 2-carboxy-phenyl, whilst the abovementioned 2-carboxy-phenyl group may additionally be substituted in the phenyl nucleus
by a fluorine, chlorine or bromine atom,
by a C1-3-alkyl, hydroxy, C1-3-alkoxy, C1-3-alkylsulphonyloxy or morpholino group,
by an n-C2-3-alkoxy group substituted in the 2 or 3 position by a di-(C1-3-alkyl)-amino group,
by an N-methyl-N-(n-C2-3-alkyl)-amino group substituted in the 2 or 3 position by a di- (C1-3-alkyl)-amino group,
by a C1-4-alkylaminocarbonyl, N-(pyridinylmethyl)-aminocarbonyl, pyrrolidinoaminocarbonyl or piperidinoaminocarbonyl group and may additionally be substituted by another fluorine atom or by another methoxy group,
or a physiologically acceptable salt thereof.

### Claim 6 (depends on 1)

A pharmaceutical composition containing a compound according to claim 1 together with one or more inert carriers and/or diluents.

### Claim 7

A compound selected from the group consisting of:
(a) trans-3-(3,4-dichlorophenyl)but-2-enoic acid-N-(2-carboxy-5-chloro-phenyl)-amide
(b) trans-3-(3,4-dichlorophenyl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide,
(c) trans-3-(3,4-dichlorophenyly-but-2-enoic acid-N-(2-carboxy-4-methyl-phenyl)-amide,
(d) trans-3-(3,4-dichlorophenyl)but2enoic acid-N-(2-carboxy-4,5-dimethoxy-phenyl)-amide,
(e) trans-3-(3,4-dichlorophenyl)-but-2-enoic acid-N-(2-carboxy-4-methoxy-5-methyl-phenyl)-amide,
(f) trans-3-(3,4-dichlorophenyl)-but-2-enoic acid-N-(4-bromo-2-carboxy-6-methyl-phenyl)amide,
(g) trans-3-(3,4-dichlorophenyl)-but-2-enoic acid-N-(2-carboxy-5-nitro-phenyl)-amide,
(h) trans-3-(3,4-dichlorophenyl)-but-2-enoic acid-N-(2-carboxy-4-iodo-phenyl)-amide,
(i) trans-3-(3,4-dichlorophenyl)-but-2-enoic acid-N-(2-carboxy-4-chlorophenyl)-amide,
(j) trans-3-(3,4-dichlorophenyl)-pent-2-enoic acid-N-(2-carboxy-4,5-dimethoxy-phenyl)-amide,
(k) trans-3-(3,4-dichloro-phenyl)-but-2-enoic acid-N-[2-carboxy-4-(morpholin-4-yl)-phenyl]-amide,
(l) trans-3-(3,4-dichloro-phenyl)-but-2-enoic acid-N-(2-carboxy-4-dimethylamino-phenyl)amide,
(m) trans-3-(2,4-dichlorophenyl)-but-2-enoic acid-N-(2-carboxy-4-fluoro-phenyl)-amide,
(n) trans-3-(2,4-dichlorophenyl)-but-2-enoic acid-N-(2-carboxy-4,5-dimethoxy-phenyl)-amide,
(o) trans-3-(3,4-dichloro-phenyl)-but-2-enoic acid-N-(2-carboxy-4-fluoro-phenyl)-amide,
(p) trans-3-(3,4-difluorophenyl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide,
(q) trans-3-(3,4-dibromophenyl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide,
(r) trans-3-(3,4-dibromophenyl)-but-2-enoic acid-N-(2-carboxy-4,5-dimethoxy-phenyl)-amide,
(s) trans-3-(3,4-dibromophenyl)-but-2-enoic acid-N-(2-carboxy-4-metboxy-5-methyl-phenyl)-amide,
(t) trans-3-(3,5-dibromo-4-ethylphenyl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide,
(u) trans-3-(3-bromo-4-chlorophenyl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide,
(v) trans-3-(3-chloro-4-bromophenyl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide,
(w) trans-3-(3-bromo-4-chlorophenyl)-but-2-enoic acid-N-(2-carboxy-4,5-dimethoxy-phenyl)-amide, and
(x) trans-3-(3-chloro-4-bromophenyl)-but-2-enoic acid-N-(2-carboxy-4,5-dimethoxy-phenyl)-amide,
or a physiologically acceptable salt thereof.

### Claim 8

Trans-3-(3,4-dichlorophenyl)-but-2-enoic acid-N-(2-carboxy-4,5-dimethoxy-phenyl)-amide or a physiologically acceptable salt thereof.

### Claim 9

Trans-3-(3,4-dichlorophenyl)-but-2-enoic acid-N-(2-carboxy-4-methoxy-5-methyl-phenyl)-amide or a physiologically acceptable salt thereof.
